Viewing Study NCT04338620


Ignite Creation Date: 2025-12-25 @ 4:23 AM
Ignite Modification Date: 2026-01-28 @ 5:00 PM
Study NCT ID: NCT04338620
Status: UNKNOWN
Last Update Posted: 2023-03-06
First Post: 2020-04-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Camrelizumab Combined With Albumin-bound Paclitaxel and Platinum in Neoadjuvant Treatment of Resectable NSCLC
Sponsor: Tang-Du Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small-cell Lung Cancer (NSCLC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Camrelizumab View
None neoadjuvant treatment View